Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Etude Observationnelle Biologique Sur le Syndrome de Sevrage Des Inhibiteurs de Tyrosine Kinase Dans la Leucémie Myéloïde Chronique.

NCT03996096 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT03996096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03996096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Etude Observationnelle Biologique Sur le Syndrome de Sevrage Des Inhibiteurs de Tyrosine Kinase Dans la Leucémie Myéloïde Chronique.
Lead sponsor
University Hospital, Caen
Phase
Observational
Overall status
Completed
Start date
April 23, 2019
Completion date
March 16, 2023
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia, tyrosine kinase inhibitor, withdrawal syndrome